Literature DB >> 1653292

Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid.

S Rubattu1, F W Quimby, J E Sealey.   

Abstract

The renin gene is expressed, primarily as prorenin, in the ovary, uterus and placenta. High concentrations of prorenin are present in human ovarian follicular and amniotic fluids and ovarian secretion causes increases in plasma prorenin at mid-menstrual cycle and during pregnancy. Plasma prorenin is low but detectable in nephrectomized human subjects. Comparative studies in female cats revealed several differences. Cat plasma prorenin became undetectable after bilateral nephrectomy. Neither plasma prorenin nor renin increased during pregnancy. Renin and prorenin were undetectable in ovarian follicular, amniotic and allantoic fluids. Human chorionic gonadotropin-induced ovulation caused only small increases in plasma prorenin. In contrast, renin and prorenin were clearly present in extracts of reproductive tissues. Ovarian total renin was lowest during anestrus (169 +/- 27 ng/g per h) and estrus (258 +/- 58 ng/g per h) and increased with ovulation (385 +/- 31 ng/g per h). Higher ovarian levels were found during pseudopregnancy (1370-2030 ng/g per h) and early pregnancy (1312-2700 ng/g per h) and in the placental chorion disc of early pregnancy (1755-1184 ng/g per h). In the uterus, the level was 98-183 ng/g per h during gestation. These results demonstrate that, in marked contrast to humans, only the cat kidney secretes prorenin into body fluids. Nonetheless, total renin increases in cat ovaries during follicle maturation, ovulation, pregnancy and pseudopregnancy, in the uterus during gestation and in the placental chorion disc. These results are consistent with an autocrine or paracrine role for the tissue renin system in cat reproductive tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653292     DOI: 10.1097/00004872-199106000-00008

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

Review 1.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

2.  Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; Courtney Gruver; Cheryl Moorefield; K Bridget Brosnihan
Journal:  Reprod Biol Endocrinol       Date:  2010-11-04       Impact factor: 5.211

3.  A series of self-measurements by the patient is a reliable alternative to ambulatory blood pressure measurement.

Authors:  M M Brueren; H J Schouten; P W de Leeuw; G A van Montfrans; J W van Ree
Journal:  Br J Gen Pract       Date:  1998-09       Impact factor: 5.386

4.  Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; K Bridget Brosnihan
Journal:  Endocrine       Date:  2007-11-15       Impact factor: 3.633

Review 5.  Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.

Authors:  Lauren Anton; K Bridget Brosnihan
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-10

6.  Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; Kathryn Stovall; Patricia E Gallagher; Debra I Diz; Cheryl Moorefield; Courtney Gruver; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.